132 related articles for article (PubMed ID: 15470760)
1. Trial of antiretroviral for HIV prevention on hold.
Ahmad K
Lancet Infect Dis; 2004 Oct; 4(10):597. PubMed ID: 15470760
[No Abstract] [Full Text] [Related]
2. Cambodia: can a drug provide some protection?
Cohen J
Science; 2003 Sep; 301(5640):1660-1. PubMed ID: 14500956
[No Abstract] [Full Text] [Related]
3. AIDS research. Cambodian leader throws novel prevention trial into limbo.
Cohen J
Science; 2004 Aug; 305(5687):1092. PubMed ID: 15326323
[No Abstract] [Full Text] [Related]
4. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
5. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
6. Summaries for patients. Treatment for resistant HIV-1 infection.
Ann Intern Med; 2003 Sep; 139(5 Pt 1):I22. PubMed ID: 12965954
[No Abstract] [Full Text] [Related]
7. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
8. Tenofovir gel studied.
AIDS Patient Care STDS; 2002 Aug; 16(8):401-2. PubMed ID: 12227991
[No Abstract] [Full Text] [Related]
9. Can AIDS drug also prevent HIV infection?
AIDS Read; 2004 Jan; 14(1):14. PubMed ID: 14959699
[No Abstract] [Full Text] [Related]
10. Renal safety of tenofovir in HIV treatment-experienced patients.
Izzedine H; Isnard-Bagnis C; Hulot JS; Vittecoq D; Cheng A; Jais CK; Launay-Vacher V; Deray G
AIDS; 2004 Apr; 18(7):1074-6. PubMed ID: 15096814
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
Squires K; Pozniak AL; Pierone G; Steinhart CR; Berger D; Bellos NC; Becker SL; Wulfsohn M; Miller MD; Toole JJ; Coakley DF; Cheng A;
Ann Intern Med; 2003 Sep; 139(5 Pt 1):313-20. PubMed ID: 12965939
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir ready for approval.
AIDS Patient Care STDS; 2001 Jul; 15(7):399. PubMed ID: 11483167
[No Abstract] [Full Text] [Related]
13. AIDS drug trial turned away; protests by prostitutes in Cambodia ended Tenofovir testing.
Cha AE
Washington Post; 2006 May; ():A10, A14. PubMed ID: 16856292
[No Abstract] [Full Text] [Related]
14. AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
Grant RM; Buchbinder S; Cates W; Clarke E; Coates T; Cohen MS; Delaney M; Flores G; Goicochea P; Gonsalves G; Harrington M; Lama JR; MacQueen KM; Moore JP; Peterson L; Sanchez J; Thompson M; Wainberg MA
Science; 2005 Sep; 309(5744):2170-1. PubMed ID: 16195446
[No Abstract] [Full Text] [Related]
15. Tenofovir, equivalence, and noninferiority.
Parienti JJ
JAMA; 2004 Oct; 292(16):1951; author reply 1951-2. PubMed ID: 15507576
[No Abstract] [Full Text] [Related]
16. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
17. Prodrug of tenofovir diphosphate approved for combination HIV therapy.
Thompson CA
Am J Health Syst Pharm; 2002 Jan; 59(1):18. PubMed ID: 11813460
[No Abstract] [Full Text] [Related]
18. [96-week treatment outcome confirms long term efficacy of tenofovir DF].
Dtsch Med Wochenschr; 2003 May; 128(19):1074-5. PubMed ID: 12774796
[No Abstract] [Full Text] [Related]
19. Marked elevation of the creatine phosphokinase level in a patient receiving tenofovir.
Shere-Wolfe KD; Verley JR
Clin Infect Dis; 2002 Nov; 35(9):1137. PubMed ID: 12384851
[No Abstract] [Full Text] [Related]
20. Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
Antoniou T; Park-Wyllie LY; Tseng AL
Pharmacotherapy; 2003 Jan; 23(1):29-43. PubMed ID: 12523458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]